{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:34:26Z","timestamp":1790505266067,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003137","name":"Fondation pour la Recherche sur la Biodiversite","doi-asserted-by":"publisher","award":["ANR-10-IAIHU-06"],"award-info":[{"award-number":["ANR-10-IAIHU-06"]}],"id":[{"id":"10.13039\/501100003137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000967","name":"American Health Assistance Foundation","doi-asserted-by":"publisher","award":["G2006-118"],"award-info":[{"award-number":["G2006-118"]}],"id":[{"id":"10.13039\/100000967","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005737","name":"Universit\u00e9 Pierre et Marie Curie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004708","name":"Hill, Holliday, Connors, Cosmopulos","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["Hospitalo-Universitaire-6"],"award-info":[{"award-number":["Hospitalo-Universitaire-6"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001961","name":"AXA Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2016YFC1300500-03"],"award-info":[{"award-number":["2016YFC1300500-03"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["NIHR01AG032441-01"],"award-info":[{"award-number":["NIHR01AG032441-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["NIHR21 AG049237"],"award-info":[{"award-number":["NIHR21 AG049237"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RO1AG025888"],"award-info":[{"award-number":["RO1AG025888"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.biopsych.2017.02.007","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T16:16:21Z","timestamp":1490631381000},"page":"447-455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer\u2019s Disease Dementia in Individuals With Mild Cognitive Impairment"],"prefix":"10.1016","volume":"83","author":[{"given":"Yong","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Mullan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Lista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Leyhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Laske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Rujescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Wallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2017.02.007_bib1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer\u2019s disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2017.02.007_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.biopsych.2017.02.007_bib3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrd3115","article-title":"Biomarkers for Alzheimer\u2019s disease: Academic, industry and regulatory perspectives","volume":"9","author":"Hampel","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biopsych.2017.02.007_bib4","doi-asserted-by":"crossref","first-page":"a006262","DOI":"10.1101\/cshperspect.a006262","article-title":"Biochemistry of amyloid \u03b2-protein and amyloid deposits in Alzheimer disease","volume":"2","author":"Masters","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.biopsych.2017.02.007_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: A genetic perspective","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2017.02.007_bib6","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature08538","article-title":"Multimodal techniques for diagnosis and prognosis of Alzheimer\u2019s disease","volume":"461","author":"Perrin","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2017.02.007_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroimage.2010.02.036","article-title":"Quantifying the effects of normal ageing on white matter structure using unsupervised tract shape modelling","volume":"51","author":"Bastin","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2017.02.007_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2017.02.007_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneurol.2009.218","article-title":"The secretases: Enzymes with therapeutic potential in Alzheimer disease","volume":"6","author":"De Strooper","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.biopsych.2017.02.007_bib10","doi-asserted-by":"crossref","first-page":"12787","DOI":"10.1523\/JNEUROSCI.3657-09.2009","article-title":"The beta-secretase enzyme BACE in health and Alzheimer\u2019s disease: Regulation, cell biology, function, and therapeutic potential","volume":"29","author":"Vassar","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2017.02.007_bib11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2017.02.007_bib12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/990107","article-title":"Membrane-anchored aspartyl protease with Alzheimer\u2019s disease beta-secretase activity","volume":"402","author":"Yan","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2017.02.007_bib13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/990114","article-title":"Purification and cloning of amyloid precursor protein beta-secretase from human brain","volume":"402","author":"Sinha","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2017.02.007_bib14","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archneur.59.9.1381","article-title":"Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease","volume":"59","author":"Fukumoto","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2017.02.007_bib15","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ana.10208","article-title":"Increased expression of the amyloid precursor beta-secretase in Alzheimer\u2019s disease","volume":"51","author":"Holsinger","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2017.02.007_bib16","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1073\/pnas.0205689101","article-title":"Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer\u2019s disease patients","volume":"101","author":"Li","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2017.02.007_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nm0103-3","article-title":"Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease","volume":"9","author":"Yang","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.biopsych.2017.02.007_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajpath.2013.10.002","article-title":"High activities of BACE1 in brains with mild cognitive impairment","volume":"184","author":"Cheng","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.biopsych.2017.02.007_bib19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1471-4159.2011.07412.x","article-title":"The Swedish APP mutation alters the effect of genetically reduced BACE1 expression on the APP processing","volume":"119","author":"Rabe","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2017.02.007_bib20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng0892-345","article-title":"A pathogenic mutation for probable Alzheimer\u2019s disease in the APP gene at the N-terminus of beta-amyloid","volume":"1","author":"Mullan","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2017.02.007_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2017.02.007_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.tips.2013.01.008","article-title":"\u03b2-Secretase: Its biology as a therapeutic target in diseases","volume":"34","author":"Wang","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biopsych.2017.02.007_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/00365510701864610","article-title":"Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer\u2019s disease","volume":"69","author":"Hampel","year":"2009","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.biopsych.2017.02.007_bib24","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archpsyc.64.6.718","article-title":"Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment","volume":"64","author":"Zhong","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2017.02.007_bib25","doi-asserted-by":"crossref","first-page":"9025","DOI":"10.1021\/jm300118s","article-title":"Design and synthesis of potent, orally efficacious hydroxyethylamine derived \u03b2-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors","volume":"55","author":"Dineen","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.biopsych.2017.02.007_bib26","doi-asserted-by":"crossref","first-page":"9009","DOI":"10.1021\/jm300119p","article-title":"Design and preparation of a potent series of hydroxyethylamine containing \u03b2-secretase inhibitors that demonstrate robust reduction of central \u03b2-amyloid","volume":"55","author":"Weiss","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.biopsych.2017.02.007_bib27","doi-asserted-by":"crossref","first-page":"16507","DOI":"10.1523\/JNEUROSCI.3647-11.2011","article-title":"Robust central reduction of amyloid-\u03b2 in humans with an orally available, non-peptidic \u03b2-secretase inhibitor","volume":"31","author":"May","year":"2011","journal-title":"J Neurosci"},{"issue":"5 suppl","key":"10.1016\/j.biopsych.2017.02.007_bib28","first-page":"S411","article-title":"Lessons from a BACE1 inhibitor trial: Off-site but not off base","volume":"10","author":"Lahiri","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.biopsych.2017.02.007_bib29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1474-4422(13)70276-X","article-title":"Targeting the \u03b2 secretase BACE1 for Alzheimer\u2019s disease therapy","volume":"13","author":"Yan","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.biopsych.2017.02.007_bib30","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1039\/C3CS60460H","article-title":"BACE1 (\u03b2-secretase) inhibitors for the treatment of Alzheimer\u2019s disease","volume":"43","author":"Ghosh","year":"2014","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.biopsych.2017.02.007_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3233\/JAD-2005-7306","article-title":"Mild cognitive impairment (MCI) represents early-stage Alzheimer\u2019s disease","volume":"7","author":"Morris","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2017.02.007_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3233\/JAD-2005-7307","article-title":"Mild cognitive impairment: Is it Alzheimer\u2019s disease or not?","volume":"7","author":"Petersen","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2017.02.007_bib33","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMcp0910237","article-title":"Clinical practice. Mild cognitive impairment","volume":"364","author":"Petersen","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2017.02.007_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-2010-1367","article-title":"BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology","volume":"20","author":"Mulder","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2017.02.007_bib35","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/awn034","article-title":"Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer\u2019s disease","volume":"131","author":"Ewers","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2017.02.007_bib36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3233\/JAD-2011-091153","article-title":"Increased CSF-BACE1 activity associated with decreased hippocampus volume in Alzheimer\u2019s disease","volume":"25","author":"Ewers","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2017.02.007_bib37","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1526-4610.2011.01959.x","article-title":"Incidence of post-dural puncture headache in research volunteers","volume":"51","author":"de Almeida","year":"2011","journal-title":"Headache"},{"key":"10.1016\/j.biopsych.2017.02.007_bib38","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000311703","article-title":"Low incidence of post-lumbar puncture headache in 1,089 consecutive memory clinic patients","volume":"63","author":"Zetterberg","year":"2010","journal-title":"Eur Neurol"},{"key":"10.1016\/j.biopsych.2017.02.007_bib39","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2017.02.007_bib40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.biopsych.2017.02.007_bib41","first-page":"641","article-title":"Consortium to establish a registry for Alzheimer\u2019s disease (CERAD) clinical and neuropsychological assessment of Alzheimer\u2019s disease","volume":"24","author":"Morris","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.biopsych.2017.02.007_bib42","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.1988.01800360017003","article-title":"The Composite International Diagnostic Interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures","volume":"45","author":"Robins","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2017.02.007_bib43","doi-asserted-by":"crossref","first-page":"25859","DOI":"10.1074\/jbc.M302622200","article-title":"BACE1- and BACE2-expressing human cells: Characterization of beta-amyloid precursor protein-derived catabolites, design of a novel fluorimetric assay, and identification of new in vitro inhibitors","volume":"278","author":"Andrau","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2017.02.007_bib44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1515\/CCLM.2011.086","article-title":"Tau and p-tau as CSF biomarkers in dementia: a meta-analysis","volume":"49","author":"van Harten","year":"2011","journal-title":"Clin Chem Lab Med"},{"issue":"pt 9","key":"10.1016\/j.biopsych.2017.02.007_bib45","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1093\/brain\/aww160","article-title":"Pittsburgh compound B imaging and cerebrospinal fluid amyloid-\u03b2 in a multicentre European memory clinic study","volume":"139","author":"Leuzy","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2017.02.007_bib46","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jalz.2012.05.2116","article-title":"Development of biomarkers to chart all Alzheimer\u2019s disease stages: The royal road to cutting the therapeutic Gordian Knot","volume":"8","author":"Hampel","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.biopsych.2017.02.007_bib47","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrneurol.2012.202","article-title":"Alzheimer disease: From inherited to sporadic AD\u2014crossing the biomarker bridge","volume":"8","author":"Hampel","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.biopsych.2017.02.007_bib48","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrd3842","article-title":"Sting of Alzheimer\u2019s failures offset by upcoming prevention trials","volume":"11","author":"Mullard","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biopsych.2017.02.007_bib49","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/485426a","article-title":"US government sets out Alzheimer\u2019s plan","volume":"485","author":"Wadman","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2017.02.007_bib50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/17520363.1.1.59","article-title":"Aspects of beta-amyloid as a biomarker for Alzheimer\u2019s disease","volume":"1","author":"Andreasson","year":"2007","journal-title":"Biomark Med"},{"key":"10.1016\/j.biopsych.2017.02.007_bib51","doi-asserted-by":"crossref","first-page":"15751","DOI":"10.1523\/JNEUROSCI.3588-11.2011","article-title":"Synaptic deficits are rescued in the p25\/Cdk5 model of neurodegeneration by the reduction of \u03b2-secretase (BACE1)","volume":"31","author":"Giusti-Rodr\u00edguez","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2017.02.007_bib52","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1038\/emboj.2012.173","article-title":"Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons","volume":"31","author":"Kuhn","year":"2012","journal-title":"EMBO J"},{"key":"10.1016\/j.biopsych.2017.02.007_bib53","unstructured":"Shen Y, He P, Cheng X, Ewers M, Sabbagh M, Lehe T, et al. (2011): Plasma BACE1 levels are increased in patients of mild cognitive impairment and Alzheimer\u2019s disease. Presented at the Alzheimer\u2019s Association 13th International Conference on Alzheimer\u2019s Disease and Related Disorders, July 16\u201321, Paris, France."},{"key":"10.1016\/j.biopsych.2017.02.007_bib54","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/archneur.65.8.1102","article-title":"Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease","volume":"65","author":"Zetterberg","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2017.02.007_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.dadm.2016.04.001","article-title":"Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile","volume":"3","author":"Winston","year":"2016","journal-title":"Alzheimers Dement (Amst)"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322317300987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322317300987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:00:58Z","timestamp":1762099258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322317300987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0006322317300987"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2017.02.007","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727464644.793548669","asserted-by":"object"}]},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer\u2019s Disease Dementia in Individuals With Mild Cognitive Impairment","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2017.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Society of Biological Psychiatry, 2017.","name":"copyright","label":"Copyright"}]}}